46 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... #Medications #Cardiology ... #Pharmacology # ... Management #Therapy ... #Table #Overview
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Antiarrhythmic Drugs ... Antiarrhythmic #Drugs ... #Medications #Pharmacology ... #Cardiology #Table
Drugs for Heart Failure

#medications #chf #pathophysiology #cardiology #pharmacology
Drugs for Heart ... #medications #chf ... pathophysiology #cardiology ... #pharmacology
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... Loop #Thiazide #CHF ... #Cardiology #Management
Membrane Actions of Antiarrhythmic Drugs

#Membrane #Channels #Actions #Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table
Antiarrhythmic Drugs ... Antiarrhythmic #Drugs ... #Medications #Pharmacology ... #Cardiology #Table
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... American College of Cardiology ... #CHF #guideline ... #ACCAHA2017 #cardiology ... #treatment #algorithm
"Suggested management of chronic heart failure. Adapted from the 2016 European Society of Cardiology guidelines"-McMaster Textbook
"Suggested management ... European Society of Cardiology ... Pharmacotherapy of HFrEF #CHF ... #Management #HFrEF ... #Cardiology #Algorithm
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Arrhythmias / CHB ... pharmacology ... #pharmacology # ... inopressors #diagnosis #management ... #comparison #table
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... #medications #drugs ... #cardiology #warfarin ... #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF ... ventricular hypertrophy; MCS ... #CHF #Congestive ... Stages #ACCAHA #Algorithm ... #Management #Cardiology